Patents Assigned to Hemogen, Inc. - Justia Patents Search

Patents Assigned to Hemogen, Inc.

Method for treating non-ocular epithelial disorders via increasing heme oxygenase levels and/or decreasing levels of arachidonic acid derivatives

Patent number: 5783201

Abstract: Vitamin B12 is used to stimulate heme oxygenase production. In turn, levels of the molecules 12(R)-HETE and 12(R)-DIHETE, which are arachidonic acid derivatives, are reduced. Various topical formulations containing vitamin B12, but no other vitamins, are described.

Type: Grant

Filed: April 3, 1997

Date of Patent: July 21, 1998

Assignee: Hemogen, Inc.

Inventors: Richard D. Levere, Nadar G. Abraham, Michal L. Schwartzman, Michael W. Dunn
Method for treating non-ocular epithelial disorders via increasing heme oxygenase levels and/or decreasing levels of arachidonic acid derivatives

Patent number: 5674505

Abstract: Vitamin B12 is used to stimulate heme oxygenase production. In turn, levels of the molecules 12(R)-HETE and 12(R)-DIHETE, which are arachidonic acid derivatives, are reduced. Various topical formulations containing vitamin B12, but no other vitamins, are described.

Type: Grant

Filed: August 2, 1994

Date of Patent: October 7, 1997

Assignee: Hemogen, Inc.

Inventors: Richard D. Levere, Nadar G. Abraham, Michal L. Schwartzman, Michael W. Dunn